REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

标题
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
作者
关键词
Farnesoid X receptor, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, NASH, Obeticholic acid
出版物
Contemporary Clinical Trials
Volume 84, Issue -, Pages 105803
出版商
Elsevier BV
发表日期
2019-06-29
DOI
10.1016/j.cct.2019.06.017

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started